# Mark Raffeld

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-raffeld/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,214 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 113 |
| i10-index | 384 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5024701461 |
| ORCID iD | 0000-0002-4039-6957 |
| Works | 795 |

## Researcher papers

Showing 12 of 18.

- [Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes](https://scholariq.org/papers/cancer-regression-and-autoimmunity-in-patients-after-clonal-repopulation-with/)
- [Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1](https://scholariq.org/papers/tumor-regression-in-patients-with-metastatic-synovial-cell-sarcoma-and-melanoma/)
- [Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor](https://scholariq.org/papers/chemotherapy-refractory-diffuse-large-b-cell-lymphoma-and-indolent-b-cell/)
- [Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19](https://scholariq.org/papers/eradication-of-b-lineage-cells-and-regression-of-lymphoma-in-a-patient-treated/)
- [The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia](https://scholariq.org/papers/the-lymph-node-microenvironment-promotes-b-cell-receptor-signaling-nf-b/)
- [A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response](https://scholariq.org/papers/a-pilot-trial-using-lymphocytes-genetically-engineered-with-an-ny-eso-1-reactive/)
- [Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma](https://scholariq.org/papers/human-mesenchymal-stem-cells-exert-potent-antitumorigenic-effects-in-a-model-of/)
- [B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma](https://scholariq.org/papers/b-cell-maturation-antigen-is-a-promising-target-for-adoptive-t-cell-therapy-of/)
- [Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome](https://scholariq.org/papers/mutations-in-gata2-are-associated-with-the-autosomal-dominant-and-sporadic/)
- [Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma](https://scholariq.org/papers/synergy-between-basic-fibroblast-growth-factor-and-hiv-1-tat-protein-in/)
- [Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma](https://scholariq.org/papers/pilot-trial-of-adoptive-transfer-of-chimeric-antigen-receptor-transduced-t-cells/)
- [MGMT Status as a Clinical Biomarker in Glioblastoma](https://scholariq.org/papers/mgmt-status-as-a-clinical-biomarker-in-glioblastoma/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.